UROpédia CANADA

PROGRAMMES SUR DEMANDE !

 

button

David Laidley & Ramy Saleh

RELATE: Expert Insights on When and How to Use RLT in Canadian Patients with mCRPC

Section 3
Nombre maximal de crédits: 3.0
avril 2025

Alejandro Berlin, Frédéric Pouliot & Ricardo Rendon

Evolution in the Management of Oligometastatic Prostate Cancer: What Does the Evidence Show When Selecting the Treatment of Choice?

Section 3
Nombre maximal de crédits: 3.0
avril 2025

Bernie Eigl, Wassim Kassouf & Srikala Sridhar

Advancing Care in Muscle Invasive Bladder Cancer (MIBC): Current Insights and Multi-Disciplinary Strategies

Section 3
Nombre maximal de crédits: 3.0
avril 2025

Complications and blood loss after invasive treatments for small renal masses

Section 3
Nombre maximal de crédits: 3.0
avril 2025

2025 Canadian Urological Association Guideline: Selected treatment recommendations for interstitial cystitis/bladder pain syndrome

Section 3
Nombre maximal de crédits: 3.0
mars 2025

Scott Edwards, Avril Lusty & Ricardo Rendon

Comprehensive mCSPC Management for Urologists: Debunking Myths, Optimizing Outcomes, and Supporting Patient-Centred Intensification

Section 3
Nombre maximal de crédits: 3.0
mars 2025

Moderator: Hassan Razvi || Speaker: Sara Clark

Federal Election Readiness

mars 2025

Aly-Khan Lalani & Ramy Saleh

Navigating the Evolving Landscape of Renal Cell Carcinoma: From Case Studies to Comprehensive Care

Section 3
Nombre maximal de crédits: 3.0
mars 2025

14th Canadian Kidney Cancer Forum

février 2025

Aly-Khan Lalani & Peter Black

Canadian Expert discussion on the treatment and management considerations for MIBC treatment regimens

Section 3
Nombre maximal de crédits: 1.5
mars 2025